Business Description
ViGenCell Inc
ISIN : KR7308080001
Compare
Compare
Traded in other countries / regions
308080.Korea IPO Date
2021-08-25Description
ViGenCell Inc specializes in immune cell therapy products. The companies various immune cell therapies has contributed to prolonged life expectancy and much enhanced quality of life for patients suffering from incurable diseases.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.71 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | -0.59 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 73.9 | |||||
3-Year EPS without NRI Growth Rate | 68.8 | |||||
3-Year FCF Growth Rate | 44.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 74.45 | |||||
9-Day RSI | 56.82 | |||||
14-Day RSI | 46.66 | |||||
6-1 Month Momentum % | -29.77 | |||||
12-1 Month Momentum % | -41.37 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.35 | |||||
Quick Ratio | 6.35 | |||||
Cash Ratio | 6.2 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -232.7 | |||||
Shareholder Yield % | -0.24 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -22.61 | |||||
ROA % | -20.05 | |||||
ROIC % | -56 | |||||
ROC (Joel Greenblatt) % | -69.27 | |||||
ROCE % | -21.72 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.03 | |||||
Price-to-Tangible-Book | 1.06 | |||||
EV-to-EBIT | -1.68 | |||||
EV-to-EBITDA | -2.26 | |||||
EV-to-FCF | -1.76 | |||||
Price-to-Net-Current-Asset-Value | 1.65 | |||||
Price-to-Net-Cash | 1.7 | |||||
Earnings Yield (Greenblatt) % | -59.38 | |||||
FCF Yield % | -22.27 |